RAD51 (Q06609) variants and mutations
RAD51 (also known as Q06609) is a human protein-coding gene encoding a DNA repair protein RAD51 homolog 1 protein. Its annotated function is homologous DNA recombinase that catalyzes strand exchange, a key step in DNA repair through homologous recombination (HR). It is annotated at the chromosome. This analysis covers 638 RAD51 variants and mutations. Of these, 61% have computational variant effect predictions. Disease context includes Fanconi anemia complementation group R, Fanconi anemia, and mirror movements 2. Example RAD51 variants include A2T, A2V, and M3I.
Variant analysis overview
- Gene: RAD51
- Protein: Q06609
- UniProt accession: Q06609
- Organism: Homo sapiens
- Variants analyzed: 638
- Variant scope: all variants
- Completed: 2026-09-02
Variant and mutation evidence
- Variant composition: 464 unspecified-consequence records; 7 frameshift variants; 1 in-frame insertions; 108 missense variants; 44 synonymous variants; 7 stop-gained variants; 3 splice-region variants; 6 substitution
- Prediction scores: 388 variants have prediction scores (61% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Fanconi anemia complementation group R, Fanconi anemia, mirror movements 2, cancer, breast cancer, hereditary breast carcinoma, Hereditary breast cancer, hereditary disease, familial congenital mirror movements, alcohol drinking, stroke disorder, breast carcinoma.
Protein structure and variant hotspots
- Protein features: 1 domains; 11 binding sites; 6 post-translational modification sites.
- Structural context: 74 variants have structural context.
- PTM context: 19 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable RAD51 variants
Examples include A2T, A2V, M3I, M3T, M3V, M3S, p.Met3 Gln4insLeu, Q4*. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2T (p.Ala2Thr), Ensembl rs2141813741, REVEL 0.15, CADD 25.90
- A2V (p.Ala2Val), Ensembl rs2141813755, REVEL 0.16, CADD 25.90
- M3I (p.Met3Ile), rs2504406185, ClinGen CA391744009, ClinVar RCV002383149, REVEL 0.12, CADD 23.60, Uncertain significance, Inborn genetic diseases
- M3T (p.Met3Thr), rs374776986, ClinGen CA268838211, ClinVar RCV003296405, Ensembl rs374776986, REVEL 0.19, CADD 23.00, Uncertain significance, Inborn genetic diseases
- M3V (p.Met3Val), rs751792276, ClinGen CA7483899, ClinVar RCV003725520, ExAC rs751792276, REVEL 0.18, CADD 17.50, Uncertain significance, not provided
- M3S (p.Met3Ser), gnomAD 15-40698765-AT-A, CADD 26.10
- p.Met3 Gln4insLeu, rs1360014899, gnomAD 15-40698765-A-ATG, CADD 18.90
- Q4* (p.Gln4Ter), Ensembl rs2141813815
- Q4H (p.Gln4His), gnomAD rs1335930270, REVEL 0.06, CADD 21.90
- Q4K (p.Gln4Lys), rs2141813815, ClinGen CA391744020, ClinVar RCV003196610, Uncertain significance, Inborn genetic diseases
- M5I (p.Met5Ile), rs2504406242, ClinGen CA391744063, ClinVar RCV002398676, REVEL 0.11, CADD 22.80, Uncertain significance, Inborn genetic diseases
- M5L (p.Met5Leu), gnomAD 15-40698771-A-C, REVEL 0.16, CADD 22.00
- L7P (p.Leu7Pro), rs1894810858, ClinGen CA391744099, ClinVar RCV003707096, gnomAD rs1894810858, REVEL 0.15, CADD 23.80, Uncertain significance, not provided
- A9V (p.Ala9Val), TOPMed rs944000401, Uncertain significance, not provided
- N10D (p.Asn10Asp), rs2504406316, ClinGen CA391744155, ClinVar RCV002438033, ClinVar RCV005098327, REVEL 0.09, CADD 22.10, Uncertain significance, not provided; Inborn genetic diseases
- A11G (p.Ala11Gly), rs1286692919, ClinGen CA391744188, ClinVar RCV002454679, gnomAD rs1286692919, REVEL 0.03, AlphaMissense 0.08, Uncertain significance, Inborn genetic diseases
- A11V (p.Ala11Val), rs1286692919, ClinGen CA391744191, ClinVar RCV004516232, AlphaMissense 0.08, MetaLR 0.13, Uncertain significance, Inborn genetic diseases
- A11A (p.Ala11Ala), rs1337153504, gnomAD 15-40698791-A-G, CADD 12.70
- D12G (p.Asp12Gly), rs1246018948, ClinGen CA391744222, ClinVar RCV003377526, gnomAD rs1246018948, REVEL 0.14, CADD 23.20, Uncertain significance, Inborn genetic diseases
- D12H (p.Asp12His), NCI-TCGA Cosmic COSV5111, cosmic curated COSV51112, Variant assessed as somatic; moderate impact.
- D12N (p.Asp12Asn), cosmic curated COSV51112, TOPMed rs1362216112, Uncertain significance, Inborn genetic diseases
- T13I (p.Thr13Ile), gnomAD 15-40698796-C-T, REVEL 0.06, CADD 22.30
- T13T (p.Thr13Thr), gnomAD 15-40698797-T-G, CADD 11.60
- S14L (p.Ser14Leu), gnomAD 15-40698799-C-T, REVEL 0.16, CADD 23.20
- S14* (p.Ser14Ter), gnomAD 15-40698799-C-A, CADD 36.00
- V15E (p.Val15Glu), TOPMed rs1159091605, gnomAD rs1159091605, REVEL 0.21, CADD 22.60
- V15L (p.Val15Leu), rs2504406440, ClinGen CA391744287, ClinVar RCV004516238, Uncertain significance, Inborn genetic diseases
- V15M (p.Val15Met), gnomAD 15-40698801-G-A, REVEL 0.03, CADD 21.30
- E17K (p.Glu17Lys), cosmic curated COSV51114, gnomAD rs1894812270, REVEL 0.19, CADD 25.60
- E18* (p.Glu18Ter), rs1487695348, NCI-TCGA Cosmic COSV9913, TOPMed rs1487695348, gnomAD rs1487695348, CADD 37.00, Variant assessed as somatic; high impact.
- E18K (p.Glu18Lys), NCI-TCGA Cosmic COSV9913, cosmic curated COSV99139, Variant assessed as somatic; moderate impact.
- S19G (p.Ser19Gly), rs755132632, ClinGen CA7483900, ClinVar RCV002344874, ExAC rs755132632, REVEL 0.07, CADD 22.50, Uncertain significance, Inborn genetic diseases
- G21D (p.Gly21Asp), cosmic curated COSV51112
- G21G (p.Gly21Gly), gnomAD 15-40698821-C-G, CADD 8.98
- P22P (p.Pro22Pro), gnomAD 15-40698824-A-C, CADD 12.50
- Q23K (p.Gln23Lys), Ensembl rs2141813952
- Q23R (p.Gln23Arg), ExAC rs781383372, gnomAD rs781383372, REVEL 0.16, CADD 22.40
- Q23Q (p.Gln23Gln), rs748148264, gnomAD 15-40698827-A-G, CADD 6.60
- P24A (p.Pro24Ala), rs2504406579, ClinGen CA391744512, ClinVar RCV002367349, ClinVar RCV006559114, Uncertain significance, not provided; Inborn genetic diseases
- P24L (p.Pro24Leu), rs1894813213, ClinGen CA391744518, ClinVar RCV002370845, gnomAD rs1894813213, REVEL 0.10, CADD 22.00, Uncertain significance, Inborn genetic diseases
- P24S (p.Pro24Ser), rs2504406579, ClinGen CA391744510, ClinVar RCV002367351, Uncertain significance, Inborn genetic diseases
- P24P (p.Pro24Pro), gnomAD 15-40698830-C-T, CADD 9.37
- I25V (p.Ile25Val), Ensembl rs1200593832
- S26L (p.Ser26Leu), cosmic curated COSV51114, gnomAD rs1180753546, REVEL 0.17, CADD 23.60
- R27L (p.Arg27Leu), rs778132081, ClinGen CA391744560, ClinVar RCV001822404, ExAC rs778132081, REVEL 0.26, CADD 23.40, Uncertain significance, not specified
- R27Q (p.Arg27Gln), rs778132081, ClinGen CA7483904, ClinVar RCV002419482, ClinVar RCV003403808, REVEL 0.14, CADD 23.10, Uncertain significance, not provided; Inborn genetic diseases
- R27W (p.Arg27Trp), rs756713380, ClinGen CA7483903, NCI-TCGA Cosmic COSV1043, cosmic curated COSV10438, REVEL 0.27, CADD 22.90, Uncertain significance, Inborn genetic diseases
- R27R (p.Arg27Arg), rs1261849229, gnomAD 15-40698839-G-A, CADD 9.03
- L28L (p.Leu28Leu), rs1457521488, gnomAD 15-40698842-A-G, CADD 12.50
- E29G (p.Glu29Gly), rs1489593050, ClinGen CA391744584, ClinVar RCV003296407, ClinVar RCV004818313, REVEL 0.35, CADD 32.00, Uncertain significance, not provided; Inborn genetic diseases
- E29Q (p.Glu29Gln), cosmic curated COSV51112
- E29D (p.Glu29Asp), gnomAD 15-40698845-G-C, REVEL 0.13, CADD 33.00
- E29E (p.Glu29Glu), gnomAD 15-40698845-G-A, CADD 24.50
- Q30* (p.Gln30Ter), cosmic curated COSV51111, gnomAD rs1894955834, CADD 38.00
- Q30H (p.Gln30His), gnomAD 15-40701066-G-C, REVEL 0.20, CADD 20.80
- C31R (p.Cys31Arg), gnomAD 15-40701067-T-C, REVEL 0.14, CADD 22.60
- C31F (p.Cys31Phe), gnomAD 15-40701068-G-T, REVEL 0.29, CADD 22.60
- G32C (p.Gly32Cys), rs2504414467, ClinGen CA391745412, ClinVar RCV002374142, REVEL 0.63, CADD 30.00, Uncertain significance, Inborn genetic diseases
- G32D (p.Gly32Asp), Ensembl rs866677917
- I33M (p.Ile33Met), NCI-TCGA Cosmic COSV5111, cosmic curated COSV51113, Variant assessed as somatic; moderate impact.
- N34T (p.Asn34Thr), rs751379027, ClinGen CA7483916, ClinVar RCV004445422, ClinVar RCV006564760, REVEL 0.06, CADD 20.00, Uncertain significance, not provided; Inborn genetic diseases
- N34I (p.Asn34Ile), gnomAD 15-40701077-A-T, REVEL 0.12, CADD 23.80
- A35D (p.Ala35Asp), rs377571591, ClinGen CA268838901, ClinVar RCV002401013, ESP rs377571591, REVEL 0.17, CADD 23.50, Uncertain significance, Inborn genetic diseases
- A35T (p.Ala35Thr), ExAC rs755292488, gnomAD rs755292488, REVEL 0.10, CADD 22.90
- A35V (p.Ala35Val), ESP rs377571591, TOPMed rs377571591, gnomAD rs377571591, REVEL 0.13, CADD 22.30, Uncertain significance
- A35A (p.Ala35Ala), rs145745388, gnomAD 15-40701081-C-T, CADD 10.50
- N36S (p.Asn36Ser), TOPMed rs1894957326, REVEL 0.10, CADD 20.20, Uncertain significance, Inborn genetic diseases
- N36N (p.Asn36Asn), rs201437876, gnomAD 15-40701084-C-T, CADD 6.63
- D37A (p.Asp37Ala), ExAC rs756092232, TOPMed rs756092232, gnomAD rs756092232, REVEL 0.62, CADD 28.00, Uncertain significance
- D37H (p.Asp37His), rs1428987216, ClinGen CA391745492, ClinVar RCV003214122, cosmic curated COSV51111, AlphaMissense 0.98, MetaLR 0.42, Uncertain significance, Inborn genetic diseases
- D37N (p.Asp37Asn), rs1428987216, ClinGen CA391745494, NCI-TCGA Cosmic COSV5111, REVEL 0.44, AlphaMissense 0.98, Uncertain significance, not specified
- D37V (p.Asp37Val), rs756092232, ClinGen CA7483920, ClinVar RCV003377525, ExAC rs756092232, REVEL 0.60, CADD 28.00, Uncertain significance, Inborn genetic diseases
- D37D (p.Asp37Asp), gnomAD 15-40701087-T-C, CADD 12.40
- V38M (p.Val38Met), gnomAD 15-40701088-G-A, REVEL 0.15, CADD 23.20
- V38V (p.Val38Val), gnomAD 15-40701090-G-A, CADD 10.30
- K40R (p.Lys40Arg), gnomAD 15-40701095-A-G, REVEL 0.28, CADD 23.10
- K40E (p.Lys40Glu), rs77029343, []
- L41F (p.Leu41Phe), ExAC rs757735432, gnomAD rs757735432, REVEL 0.47, CADD 22.60
- L41M (p.Leu41Met), rs749742647, ClinGen CA391745561, ClinVar RCV004516223, Uncertain significance, Inborn genetic diseases
- L41W (p.Leu41Trp), rs2504414670, ClinGen CA391745574, ClinVar RCV003228462, ClinVar RCV004285622, Uncertain significance, not provided; Inborn genetic diseases
- L41L (p.Leu41Leu), rs749742647, gnomAD 15-40701097-T-C, CADD 10.40
- E42* (p.Glu42Ter), gnomAD rs1302486714, CADD 38.00
- E42K (p.Glu42Lys), gnomAD 15-40701100-G-A, REVEL 0.33, CADD 22.50
- E43A (p.Glu43Ala), cosmic curated COSV10438
- E43D (p.Glu43Asp), cosmic curated COSV51113
- E43K (p.Glu43Lys), cosmic curated COSV10508, TOPMed rs1894959026
- A44G (p.Ala44Gly), rs2504414734, ClinGen CA391745624, ClinVar RCV003341695, Uncertain significance, Inborn genetic diseases
- A44T (p.Ala44Thr), cosmic curated COSV51110
- A44V (p.Ala44Val), rs2504414734, ClinGen CA391745623, ClinVar RCV003196605, Uncertain significance, Inborn genetic diseases
- G45A (p.Gly45Ala), ExAC rs779286806, gnomAD rs779286806, REVEL 0.59, CADD 27.10
- G45R (p.Gly45Arg), rs2504414757, ClinGen CA391745626, ClinVar RCV003341691, REVEL 0.57, CADD 32.00, Uncertain significance, Inborn genetic diseases
- F46C (p.Phe46Cys), ExAC rs746224582, gnomAD rs746224582, REVEL 0.22, CADD 25.20
- F46L (p.Phe46Leu), rs1298742495, ClinGen CA391745680, ClinVar RCV002396632, gnomAD rs1298742495, REVEL 0.27, CADD 17.70, Uncertain significance, Inborn genetic diseases
- H47N (p.His47Asn), NCI-TCGA Cosmic COSV5111, cosmic curated COSV51113, Variant assessed as somatic; moderate impact.
- H47R (p.His47Arg), rs768411477, ClinGen CA347169, cosmic curated COSV10940, ClinVar RCV000192085, REVEL 0.31, CADD 22.50, not provided, Mirror movements 2
- T48I (p.Thr48Ile), Ensembl rs2141819225, Uncertain significance, Inborn genetic diseases
- T48N (p.Thr48Asn), rs2141819225, ClinGen CA391745757, ClinVar RCV003301912, AlphaMissense 0.99, MetaLR 0.59, Uncertain significance, Inborn genetic diseases
- T48T (p.Thr48Thr), rs140524566, gnomAD 15-40701120-T-C, CADD 8.45
- V49A (p.Val49Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V49L (p.Val49Leu), cosmic curated COSV51112
- V49M (p.Val49Met), Ensembl rs2141819258
- E50Q (p.Glu50Gln), cosmic curated COSV51114
- E50V (p.Glu50Val), TOPMed rs999567341, gnomAD rs999567341, REVEL 0.65, CADD 28.80
- A51D (p.Ala51Asp), Ensembl rs2141819273
- A51G (p.Ala51Gly), Ensembl rs2141819273
- A51V (p.Ala51Val), Ensembl rs2141819273
- V52G (p.Val52Gly), Ensembl rs80233386
- V52I (p.Val52Ile), ExAC rs747697371, TOPMed rs747697371, gnomAD rs747697371, REVEL 0.20, CADD 21.90, Uncertain significance, Inborn genetic diseases
- A53G (p.Ala53Gly), rs2141819309, ClinGen CA391745951, ClinVar RCV003177250, REVEL 0.52, CADD 25.60, Uncertain significance, Inborn genetic diseases
- A53T (p.Ala53Thr), gnomAD rs1313509498, REVEL 0.49, CADD 25.50
- A53V (p.Ala53Val), Ensembl rs2141819309
- Y54C (p.Tyr54Cys), rs769146109, ClinGen CA7483928, ClinVar RCV004516224, ClinVar RCV005100432, AlphaMissense 0.44, MetaLR 0.36, Uncertain significance, Inborn genetic diseases; not provided
- Y54F (p.Tyr54Phe), cosmic curated COSV10508
- Y54Y (p.Tyr54Tyr), rs1448067894, gnomAD 15-40701138-T-C, CADD 10.30
- Y54S (p.Tyr54Ser), rs915100895, gnomAD 15-40701858-A-C, CADD 5.06
- Y54* (p.Tyr54Ter), gnomAD 15-40701859-C-A, CADD 28.00
- A55V (p.Ala55Val), rs145617142, ClinGen CA7483929, cosmic curated COSV51111, ClinVar RCV000904789, REVEL 0.25, CADD 22.60, Benign/Likely benign, not specified; not provided
- A55T (p.Ala55Thr), gnomAD 15-40701139-G-A, REVEL 0.26, CADD 21.40
- A55S (p.Ala55Ser), gnomAD 15-40701139-G-T, REVEL 0.23, CADD 22.30
- A55A (p.Ala55Ala), rs763034071, gnomAD 15-40701141-G-A, CADD 11.90
- P56L (p.Pro56Leu), rs1894963068, ClinGen CA391746111, ClinVar RCV002406002, ClinVar RCV004534089, AlphaMissense 0.52, MetaLR 0.31, Uncertain significance, Inborn genetic diseases
- P56S (p.Pro56Ser), rs45623838, ClinGen CA7483931, cosmic curated COSV10586, ClinVar RCV002643767, REVEL 0.26, CADD 21.80, Benign, not provided
- P56T (p.Pro56Thr), ESP rs45623838, ExAC rs45623838, TOPMed rs45623838, gnomAD rs45623838, REVEL 0.20, CADD 18.30, Benign
- P56P (p.Pro56Pro), rs774356827, gnomAD 15-40701144-A-G, CADD 9.24
- K57N (p.Lys57Asn), NCI-TCGA Cosmic COSV5111, cosmic curated COSV51112, Variant assessed as somatic; moderate impact.
- K57R (p.Lys57Arg), rs1448625265, ClinGen CA391746135, ClinVar RCV003548122, gnomAD rs1448625265, REVEL 0.16, CADD 22.30, Uncertain significance, not provided
- K58Q (p.Lys58Gln), gnomAD 15-40701148-A-C, REVEL 0.38, CADD 28.10
- K58N (p.Lys58Asn), gnomAD 15-40701150-G-T, REVEL 0.28, CADD 25.00
- L60V (p.Leu60Val), Ensembl rs1894963820
- I61M (p.Ile61Met), Ensembl rs756235073
- N62D (p.Asn62Asp), TOPMed rs1371546291, gnomAD rs1371546291, REVEL 0.07, CADD 21.80
- N62K (p.Asn62Lys), TOPMed rs1894964545, Uncertain significance, Inborn genetic diseases
- N62S (p.Asn62Ser), rs2504415255, ClinGen CA391746303, ClinVar RCV002414884, Uncertain significance, Inborn genetic diseases
- N62N (p.Asn62Asn), gnomAD 15-40701841-T-C, CADD 1.96
- I63M (p.Ile63Met), rs1427093630, ClinGen CA391746322, ClinVar RCV003214121, TOPMed rs1427093630, REVEL 0.34, CADD 23.90, Uncertain significance, Inborn genetic diseases
- I63T (p.Ile63Thr), 1000Genomes rs531275069, ExAC rs531275069, gnomAD rs531275069, REVEL 0.51, CADD 26.80
- I63S (p.Ile63Ser), gnomAD 15-40701164-T-G, REVEL 0.60, CADD 29.50
- K64T (p.Lys64Thr), gnomAD 15-40701167-A-C, REVEL 0.42, CADD 24.50
- K64N (p.Lys64Asn), gnomAD 15-40701168-G-T, REVEL 0.32, CADD 23.40
- S67I (p.Ser67Ile), rs1163399253, NCI-TCGA Cosmic COSV5111, cosmic curated COSV51113, TOPMed rs1163399253, AlphaMissense 0.96, MetaLR 0.42, Uncertain significance
- S67N (p.Ser67Asn), rs1163399253, ClinGen CA391746494, ClinVar RCV002265191, TOPMed rs1163399253, REVEL 0.43, AlphaMissense 0.96, Uncertain significance, not provided
- S67A (p.Ser67Ala), gnomAD 15-40701812-T-G, CADD 0.05
- S67Y (p.Ser67Tyr), rs2141821203, gnomAD 15-40701813-C-A, CADD 7.60
- S67F (p.Ser67Phe), rs2141821203, gnomAD 15-40701813-C-T, CADD 9.02
- S67C (p.Ser67Cys), gnomAD 15-40701819-C-G, CADD 16.10
- S67S (p.Ser67Ser), gnomAD 15-40701820-T-C, CADD 3.90
- E68D (p.Glu68Asp), rs2504415390, ClinGen CA391746538, ClinVar RCV003171523, Uncertain significance, Inborn genetic diseases
- E68K (p.Glu68Lys), gnomAD 15-40701178-G-A, REVEL 0.63, CADD 32.00
- A69P (p.Ala69Pro), rs143055953, ClinGen CA268838944, ClinVar RCV002421955, ESP rs143055953, AlphaMissense 0.71, MetaLR 0.29, Uncertain significance, Inborn genetic diseases
- A69S (p.Ala69Ser), NCI-TCGA Cosmic COSV9913, cosmic curated COSV99139, ESP rs143055953, TOPMed rs143055953, Uncertain significance
- A69T (p.Ala69Thr), rs143055953, ClinGen CA391746555, ClinVar RCV003377529, AlphaMissense 0.71, MetaLR 0.29, Uncertain significance, Inborn genetic diseases
- A69V (p.Ala69Val), gnomAD 15-40701182-C-T, REVEL 0.28, CADD 22.80
- K70I (p.Lys70Ile), cosmic curated COSV10456
- K70K (p.Lys70Lys), gnomAD 15-40701186-A-G, CADD 11.00
- A71T (p.Ala71Thr), TOPMed rs1894965382
- A71V (p.Ala71Val), Ensembl rs1894965579, REVEL 0.27, CADD 21.70
- D72A (p.Asp72Ala), rs1164062003, ClinGen CA391746627, ClinVar RCV004516226, REVEL 0.31, CADD 23.40, Uncertain significance, Inborn genetic diseases
- D72H (p.Asp72His), cosmic curated COSV10508
- D72V (p.Asp72Val), TOPMed rs1164062003, gnomAD rs1164062003, REVEL 0.47, CADD 25.00
- D72Y (p.Asp72Tyr), rs2504415492, ClinGen CA391746616, ClinVar RCV002432449, Uncertain significance, Inborn genetic diseases
- K73R (p.Lys73Arg), gnomAD rs1415120657, REVEL 0.25, CADD 23.20
- K73T (p.Lys73Thr), NCI-TCGA Cosmic COSV5111, cosmic curated COSV51114, REVEL 0.57, CADD 27.50, Variant assessed as somatic; moderate impact.
- L75L (p.Leu75Leu), rs1567038406, gnomAD 15-40701201-G-A, CADD 22.90
- A76G (p.Ala76Gly), rs2504436241, ClinGen CA391749248, ClinVar RCV002446056, Uncertain significance, Inborn genetic diseases
- E77G (p.Glu77Gly), rs1218843632, cosmic curated COSV10508, ClinGen CA391749273, ClinVar RCV003377528, CADD 8.12, Uncertain significance, Inborn genetic diseases
- E77K (p.Glu77Lys), cosmic curated COSV10940, CADD 6.51, Uncertain significance, Inborn genetic diseases; not provided
- E77* (p.Glu77Ter), gnomAD 15-40701809-G-T, CADD 29.60
- E77V (p.Glu77Val), rs1595980929, gnomAD 15-40701810-A-T, CADD 7.36
- E77E (p.Glu77Glu), gnomAD 15-40701811-G-A, CADD 0.89
- E77D (p.Glu77Asp), rs1895019186, gnomAD 15-40701811-G-T, CADD 4.11
- A78S (p.Ala78Ser), TOPMed rs1335853382, gnomAD rs1335853382, REVEL 0.29, CADD 23.90
- A78V (p.Ala78Val), rs1050671800, ClinGen CA268840906, ClinVar RCV002457680, Ensembl rs1050671800, AlphaMissense 0.60, MetaLR 0.26, Uncertain significance, Inborn genetic diseases
- A78T (p.Ala78Thr), gnomAD 15-40706183-G-A, REVEL 0.44, CADD 24.40
- A79P (p.Ala79Pro), rs2504436304, ClinGen CA391749315, ClinVar RCV004516228, Uncertain significance, Inborn genetic diseases
- A79V (p.Ala79Val), rs146489542, ClinGen CA7483962, ClinVar RCV003044243, ClinVar RCV004960923, REVEL 0.21, CADD 22.70, Uncertain significance, not provided; Inborn genetic diseases
- A79T (p.Ala79Thr), rs1595980957, gnomAD 15-40701824-G-A, CADD 4.22
- A79S (p.Ala79Ser), rs1595980957, gnomAD 15-40701824-G-T, CADD 3.46
- A79D (p.Ala79Asp), gnomAD 15-40701825-C-A, CADD 7.87
- A79A (p.Ala79Ala), gnomAD 15-40701826-C-A, CADD 1.96
- K80E (p.Lys80Glu), rs1312157762, ClinGen CA391749333, ClinVar RCV003356155, TOPMed rs1312157762, REVEL 0.32, CADD 23.10, Uncertain significance, Inborn genetic diseases
Public RAD51 analysis runs
- RAD51 analysis run — RAD51 (638 variants) — completed 2026-09-02
- RAD51 analysis run — RAD51 (638 variants) — completed 2026-09-02
- RAD51 analysis run — RAD51 (638 variants) — completed 2026-09-02